Sol-Gel Technologies Operating Income 2016-2024 | SLGL

Sol-Gel Technologies operating income from 2016 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Sol-Gel Technologies Operating Income 2016-2024 | SLGL

Sol-Gel Technologies operating income from 2016 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19B
Dr Reddy's Laboratories (RDY)$12B
BridgeBio Pharma (BBIO)$4.3B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.1B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$434M
Personalis (PSNL)$261M
Assembly Biosciences (ASMB)$98M
Evoke Pharma (EVOK)$7M
Teligent (TLGT)$0M